• Publications
  • Influence
Molecular communication between tumor-associated fibroblasts and head and neck squamous cell carcinoma.
Over the past few decades, it has become increasingly clear that the lethality of cancers depends on more than the malignant cells themselves. The environment those malignant cells are exposed to isExpand
  • 36
  • 3
Risk of Stroke and Death in Atrial Fibrillation by Type of Anticoagulation: A Propensity‐Matched Analysis
We examined the effect of novel oral anticoagulants (NOACs) compared to warfarin on the risk of death or stroke in atrial fibrillation (AF) patients in every day clinical practice.
  • 7
  • 1
Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinoma.
Noninvasive imaging methodologies are needed to assess treatment responses to novel molecular targeting approaches for the treatment of squamous cell carcinoma of the head and neck (SCCHN). ComputerExpand
  • 6
  • 1
  • PDF
Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma Progression.
Despite aggressive therapies, head and neck squamous cell carcinoma (HNSCC) is associated with a less than 50% 5-year survival rate. Late-stage HNSCC frequently consists of up to 80%Expand
  • 28
Gender differences in management and clinical outcomes of atrial fibrillation patients.
BACKGROUND Prior research has identified gender differences in the epidemiology and clinical management of atrial fibrillation (AF). The primary aim of this study is to systematically analyze aExpand
  • 13
Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation.
INTRODUCTION Although there are many different antiarrhythmic drugs (AADs) approved for rhythm management of atrial fibrillation (AF), little comparative effectiveness data exist to guide drugExpand
  • 15
Mortality risk of long-term amiodarone therapy for atrial fibrillation patients without structural heart disease.
BACKGROUND Amiodarone is often prescribed in the management of atrial fibrillation (AF) but is known to cause significant end-organ toxicities. In this study, we examined the impact of amiodarone onExpand
  • 5
  • PDF
Wavefront Field Mapping Reveals a Physiologic Network Between Drivers Where Ablation Terminates Atrial Fibrillation.
BACKGROUND Localized drivers are proposed mechanisms for persistent atrial fibrillation (AF) from optical mapping of human atria and clinical studies of AF, yet are controversial because driversExpand
  • 8
Patient Outcomes According to Adherence to Treatment Guidelines for Rhythm Control of Atrial Fibrillation
Background Although guidelines for antiarrhythmic drug therapy in atrial fibrillation (AF) were published in 2006, it remains uncertain whether adherence to these guidelines affects patient outcomes.Expand
  • 6
  • PDF
Comparing phase and electrographic flow mapping for persistent atrial fibrillation
An increasing number of methods are being used to map atrial fibrillation (AF), yet the sensitivity of identifying potential localized AF sources of these novel methods are unclear. Here, we report aExpand
  • 5